Scripta Insights Co-founder & Chief Medical Officer Paul S. Bradley, MD, at Forefront of Medical Advancement, Doses First Patient in Moderna's U.S.PRNewsWire • 07/27/20
Dr. Anthony Fauci isn't 'particularly concerned' about safety of Moderna coronavirus vaccineCNBC • 07/27/20
Moderna Shares Rebound As Biopharma Starts Late-Stage Coronavirus Vaccine Trial, Snags More FundingBenzinga • 07/27/20
Moderna’s 30,000-participant Phase 3 COVID-19 vaccine trial kicks off in the U.S.TechCrunch • 07/27/20
Moderna Starts Phase 3 Trial For Its Coronavirus Vaccine; MRNA Stock JumpsInvestors Business Daily • 07/27/20
Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) BeginsBusiness Wire • 07/27/20
Moderna's stock surges as new funding sets Phase 3 trial of COVID-19 vaccine candidate to start 'immediately'Market Watch • 07/27/20
Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine DevelopmentBenzinga • 07/27/20
Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19Business Wire • 07/26/20